Janel Corporation Reports 13.2% Revenue Growth in Q2 Fiscal 2026, Net Income Declines

Janel Corporation reported its financial results for the second quarter of fiscal 2026, revealing a consolidated revenue of $57.4 million, a 13.2% increase from $50.7 million in the same period last year. For the six months ending March 31, 2026, total revenues reached $113.5 million, up 11.2% from $102.1 million in the prior year. The growth in revenue was primarily attributed to contributions from acquired businesses, particularly in the Logistics segment, which saw a revenue increase of 16.9% year-over-year.

Despite the revenue growth, Janel's profitability faced challenges. The company reported a net income of $999,000, or $0.83 per diluted share, for the three months ended March 31, 2026, down from $1.4 million, or $1.19 per diluted share, in the prior year. For the six-month period, net income decreased to $1.7 million from $2.1 million. The decline in profitability was largely due to lower income from operations in the Life Sciences and Manufacturing segments, increased acquisition-related expenses, and the impact of non-controlling interests from the Rubicon acquisition.

Operationally, Janel has made significant strides in expanding its business through acquisitions. The company completed the acquisition of Rubicon Technology, which has been consolidated into its financials since October 2025. Additionally, Janel acquired a majority stake in Interlog USA, Inc. and Biosensis Pty Ltd in previous quarters, enhancing its capabilities in logistics and life sciences. The company also announced plans to acquire an antibody product line from BioPorto A/S for $9 million, further diversifying its offerings in the Life Sciences segment.

In terms of operational metrics, Janel's Logistics segment reported a gross profit margin of 27.9% for the three months ended March 31, 2026, an improvement from 26.9% in the prior year. The Life Sciences segment, however, experienced a decline in revenues, with a 18.4% decrease in the most recent quarter, attributed to reduced market demand and order timing. The Manufacturing segment, which includes Rubicon, reported a slight revenue increase of 1.5% for the quarter, reflecting the integration of Rubicon's operations.

Looking ahead, Janel Corporation aims to continue its growth trajectory through strategic acquisitions and organic growth initiatives. The company remains focused on enhancing its service offerings and expanding its market presence, particularly in the logistics and life sciences sectors. However, management has acknowledged the potential risks associated with market conditions and integration challenges from recent acquisitions, which could impact future performance.